[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[argenx SE](/topic/$argx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$argx/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$argx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% +37%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-07-31  
**1-Year Low**: XX% on 2024-09-24  

**Most Supportive Themes**
- **Positive CHMP Opinion for Vyvgart:** (30%) Argenx received a positive opinion from the CHMP for Vyvgart.
- **Analyst Price Targets and Strong Financial Performance:** (25%) Analysts have set high price targets for Argenx, and the company has strong financial performance.
- **Innovative Training Strategies:** (15%) Argenx is utilizing innovative strategies like VR and AR for product launch preparation.
  
**Most Critical Themes**
- **FDA Review of Vyvgart Hytrulo:** (37%)  The FDA is reviewing potential safety signals for Vyvgart Hytrulo, reporting worsening disease in patients.
- **Competition and Global Complexities:** (5%)  Argenx faces challenges from competition and complexities in the global market.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXXXX   | XX% | XX       | X% |
| Reddit  | X        | X%  | XX      | X%  | X        | X% |
| YouTube | X        | X%  | XXX     | XX% | X        | X% |
| News    | XX       | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XX       | X% |